Tekmira Pharma shares off highs after Ebola report
August 04, 2014 at 11:57 AM EDT
Tekmira Pharmaceuticals' stock reversed its initial gains after Mapp Biopharmaceutical was reported to have treated two Ebola victims with varying success.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.